For the Inventor, By the Inventor

Enter assignee name

Uniondale, NY, United States of America

Angion Biomedica Corporation

USPTO Granted Patents = 26

CIPO Patents = 2

EPO Patents = 4

Forward Citations = 116

Loading Chart...

Loading Chart...

22 inventors (with patents filed for the assignee):

Bijoy Panicker (14 out of 28 patents)

Dong Sung Lim (11 out of 11 patents)

Lambertus J W M Oehlen (10 out of 10 patents)

4. Rama K Mishra (8 out of 16 patents)

5. Dawoon Jung (8 out of 8 patents)

6. David E Zembower (6 out of 15 patents)

7. David A Eiznhamer (5 out of 5 patents)

8. An-Hu Li (3 out of 26 patents)

9. Xiaokang Zhu (3 out of 3 patents)

10. James G Tarrant (3 out of 4 patents)

11. Satish Kumar Sakilam (2 out of 2 patents)

12. Jasbir Singh (1 out of 29 patents)

13. Weizhong Cai (1 out of 2 patents)

14. Prakash Narayan (1 out of 2 patents)

15. David E Smith (1 out of 2 patents)

26 patents: Sort by Forward Citations

1. 11542256 - Vinylheterocycles as Rho-associated coiled-coil kinase (ROCK) inhibitors (2023-01-03),

2. 11504359 - Antifibrotic compounds and uses thereof (2022-11-22),

3. 11459319 - Cytochrome P450 inhibitors and uses thereof (2022-10-04),

4. 11434234 - Methods and agents for treating disease (2022-09-06),

5. 11370783 - Solid forms of (E)-3-[2-(2-thienyl)vinyl]-1H-pyrazole (2022-06-28),

6. 10899750 - Methods and compositions of small molecule modulators of hepatocyte growth factor (scatter factor) activity (2021-01-26),

7. 10875849 - Solid forms of (E)-3-[2-(2-thienyl)vinyl]-1H-pyrazole (2020-12-29),

8. 10851095 - Methods and agents for treating disease (2020-12-01),

9. 10556893 - Cytochrome P450 inhibitors and uses thereof (2020-02-11),

10. 10414760 - Cytochrome P450 inhibitors and uses thereof (2019-09-17),

11. 10287282 - Methods and agents for treating disease (2019-05-14),

12. 10195184 - Antifibrotic compounds and uses thereof (2019-02-05),

13. 9988374 - Cytochrome P450 inhibitors and uses thereof (2018-06-05),

14. 9663471 - Pyrazole derivatives as modulators of hepatocyte growth factor (scatter factor) activity (2017-05-30),

15. 9597321 - Antifibrotic compounds and uses thereof (2017-03-21),

Angion Biomedica Corporation is a clinical-stage biopharmaceutical company focused on discovering and developing novel therapeutics to treat acute organ injuries and fibrotic diseases. Their innovative approach is rooted in understanding the underlying biology of these diseases, which drives the development of potential life-saving treatments. With a commitment to improving patient outcomes, Angion Biomedica Corporation aims to address critical unmet medical needs and bring transformative treatments to the market.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Jan 6 2026

26 Patents

#1 in Uniondale, NY

#696 in New York

#12,455 in US

#24,104 in the World

Uniondale, NY, United States of America

Angion Biomedica Corporation

Forward Citations = 116

22 inventors:

Bijoy Panicker (14 out of 28 patents)

Dong Sung Lim (11 out of 11 patents)

Lambertus J W M Oehlen (10 out of 10 patents)

4. Rama K Mishra (8 out of 16 patents)

5. Dawoon Jung (8 out of 8 patents)

Please report any incorrect information to support@idiyas.com

Loading…